Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Differential regulation of Kidins220 isoforms in Huntington's disease.

Sebastián-Serrano Á, Simón-García A, Belmonte-Alfaro A, Pose-Utrilla J, Santos-Galindo M, Del Puerto A, García-Guerra L, Hernández IH, Schiavo G, Campanero MR, Lucas JJ, Iglesias T.

Brain Pathol. 2019 Jul 2. doi: 10.1111/bpa.12761. [Epub ahead of print]

PMID:
31264746
2.

CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion.

Martín-Cortázar C, Chiodo Y, Jiménez-P R, Bernabé M, Cayuela ML, Iglesias T, Campanero MR.

Haematologica. 2019 Jun 20. pii: haematol.2018.215459. doi: 10.3324/haematol.2018.215459. [Epub ahead of print]

3.

Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture.

Villahoz S, Yunes-Leites PS, Méndez-Barbero N, Urso K, Bonzon-Kulichenko E, Ortega S, Nistal JF, Vazquez J, Offermanns S, Redondo JM, Campanero MR.

Nat Commun. 2018 Nov 15;9(1):4795. doi: 10.1038/s41467-018-07071-7.

4.

New Methods for Disease Modeling Using Lentiviral Vectors.

Alfranca A, Campanero MR, Redondo JM.

Trends Mol Med. 2018 Oct;24(10):825-837. doi: 10.1016/j.molmed.2018.08.001. Epub 2018 Sep 10. Review.

PMID:
30213701
5.

CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth.

Jiménez-P R, Martín-Cortázar C, Kourani O, Chiodo Y, Cordoba R, Domínguez-Franjo MP, Redondo JM, Iglesias T, Campanero MR.

Haematologica. 2018 Oct;103(10):1669-1678. doi: 10.3324/haematol.2018.188961. Epub 2018 Jun 7.

6.

Author Correction: Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.

Pose-Utrilla J, García-Guerra L, Del Puerto A, Martín A, Jurado-Arjona J, De León-Reyes NS, Gamir-Morralla A, Sebastián-Serrano Á, García-Gallo M, Kremer L, Fielitz J, Ireson C, Pérez-Álvarez MJ, Ferrer I, Hernández F, Ávila J, Lasa M, Campanero MR, Iglesias T.

Nat Commun. 2018 Jan 30;9(1):473. doi: 10.1038/s41467-018-03022-4.

7.

Regulator of calcineurin 1 modulates vascular contractility and stiffness through the upregulation of COX-2-derived prostanoids.

García-Redondo AB, Esteban V, Briones AM, Díaz Del Campo LS, González-Amor M, Méndez-Barbero N, Campanero MR, Redondo JM, Salaices M.

Pharmacol Res. 2018 Jul;133:236-249. doi: 10.1016/j.phrs.2018.01.001. Epub 2018 Jan 5.

PMID:
29309904
8.

Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.

Pose-Utrilla J, García-Guerra L, Del Puerto A, Martín A, Jurado-Arjona J, De León-Reyes NS, Gamir-Morralla A, Sebastián-Serrano Á, García-Gallo M, Kremer L, Fielitz J, Ireson C, Pérez-Álvarez MJ, Ferrer I, Hernández F, Ávila J, Lasa M, Campanero MR, Iglesias T.

Nat Commun. 2017 Dec 22;8(1):2275. doi: 10.1038/s41467-017-02322-5. Erratum in: Nat Commun. 2018 Jan 30;9(1):473.

9.

MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.

Álvaro-Blanco J, Urso K, Chiodo Y, Martín-Cortázar C, Kourani O, Arco PG, Rodríguez-Martínez M, Calonge E, Alcamí J, Redondo JM, Iglesias T, Campanero MR.

Nucleic Acids Res. 2017 Sep 29;45(17):9960-9975. doi: 10.1093/nar/gkx641.

10.

Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.

Oller J, Méndez-Barbero N, Ruiz EJ, Villahoz S, Renard M, Canelas LI, Briones AM, Alberca R, Lozano-Vidal N, Hurlé MA, Milewicz D, Evangelista A, Salaices M, Nistal JF, Jiménez-Borreguero LJ, De Backer J, Campanero MR, Redondo JM.

Nat Med. 2017 Feb;23(2):200-212. doi: 10.1038/nm.4266. Epub 2017 Jan 9.

PMID:
28067899
11.

C/EBPβ and Nuclear Factor of Activated T Cells Differentially Regulate Adamts-1 Induction by Stimuli Associated with Vascular Remodeling.

Oller J, Alfranca A, Méndez-Barbero N, Villahoz S, Lozano-Vidal N, Martín-Alonso M, Arroyo AG, Escolano A, Armesilla AL, Campanero MR, Redondo JM.

Mol Cell Biol. 2015 Oct;35(19):3409-22. doi: 10.1128/MCB.00494-15. Epub 2015 Jul 27.

12.

Nonlinear optical 3-dimensional method for quantifying atherosclerosis burden.

Sánchez SA, Méndez-Barbero N, Santos-Beneit AM, Esteban V, Jiménez-Borreguero LJ, Campanero MR, Redondo JM.

Circ Cardiovasc Imaging. 2014 May;7(3):566-9. doi: 10.1161/CIRCIMAGING.114.001753. No abstract available.

PMID:
24847011
13.

A major role for RCAN1 in atherosclerosis progression.

Méndez-Barbero N, Esteban V, Villahoz S, Escolano A, Urso K, Alfranca A, Rodríguez C, Sánchez SA, Osawa T, Andrés V, Martínez-González J, Minami T, Redondo JM, Campanero MR.

EMBO Mol Med. 2013 Dec;5(12):1901-17. doi: 10.1002/emmm.201302842. Epub 2013 Oct 15.

14.

Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.

López-Menéndez C, Gamir-Morralla A, Jurado-Arjona J, Higuero AM, Campanero MR, Ferrer I, Hernández F, Ávila J, Díaz-Guerra M, Iglesias T.

Hum Mol Genet. 2013 Feb 1;22(3):466-82. doi: 10.1093/hmg/dds446. Epub 2012 Oct 31.

PMID:
23118350
15.

E2F4 plays a key role in Burkitt lymphoma tumorigenesis.

Molina-Privado I, Jiménez-P R, Montes-Moreno S, Chiodo Y, Rodríguez-Martínez M, Sánchez-Verde L, Iglesias T, Piris MA, Campanero MR.

Leukemia. 2012 Oct;26(10):2277-85. doi: 10.1038/leu.2012.99. Epub 2012 Apr 5.

16.

Regulator of calcineurin 1 mediates pathological vascular wall remodeling.

Esteban V, Méndez-Barbero N, Jiménez-Borreguero LJ, Roqué M, Novensá L, García-Redondo AB, Salaices M, Vila L, Arbonés ML, Campanero MR, Redondo JM.

J Exp Med. 2011 Sep 26;208(10):2125-39. doi: 10.1084/jem.20110503. Epub 2011 Sep 19.

17.

B Lymphocyte commitment program is driven by the proto-oncogene c-Myc.

Vallespinós M, Fernández D, Rodríguez L, Alvaro-Blanco J, Baena E, Ortiz M, Dukovska D, Martínez D, Rojas A, Campanero MR, Moreno de Alborán I.

J Immunol. 2011 Jun 15;186(12):6726-36. doi: 10.4049/jimmunol.1002753. Epub 2011 May 13.

18.

The neuronal protein Kidins220/ARMS associates with ICAM-3 and other uropod components and regulates T-cell motility.

Jean-Mairet RM, López-Menéndez C, Sánchez-Ruiloba L, Sacristán S, Rodríguez-Martínez M, Riol-Blanco L, Sánchez-Mateos P, Sánchez-Madrid F, Rodríguez-Fernández JL, Campanero MR, Iglesias T.

Eur J Immunol. 2011 Apr;41(4):1035-46. doi: 10.1002/eji.201040513. Epub 2011 Mar 7.

19.

E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma.

Molina-Privado I, Rodríguez-Martínez M, Rebollo P, Martín-Pérez D, Artiga MJ, Menárguez J, Flemington EK, Piris MA, Campanero MR.

Cancer Res. 2009 May 1;69(9):4052-8. doi: 10.1158/0008-5472.CAN-08-4617.

20.

A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.

Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR.

Carcinogenesis. 2009 Mar;30(3):440-8. doi: 10.1093/carcin/bgp002. Epub 2009 Jan 6.

PMID:
19126644
21.

Mechanisms involved in Burkitt's tumor formation.

Campanero MR.

Clin Transl Oncol. 2008 May;10(5):250-5. Review.

PMID:
18490240
22.

The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites.

Campanero MR, Herrero A, Calvo V.

Oncogene. 2008 Feb 21;27(9):1263-72. Epub 2007 Aug 27.

PMID:
17724474
23.

Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.

Fütterer A, Campanero MR, Leonardo E, Criado LM, Flores JM, Hernández JM, San Miguel JF, Martínez-A C.

J Clin Invest. 2005 Sep;115(9):2351-62. Epub 2005 Aug 25.

24.
25.

CpG methylation as a mechanism for the regulation of E2F activity.

Campanero MR, Armstrong MI, Flemington EK.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6481-6.

26.

Distinct cellular factors regulate the c-myb promoter through its E2F element.

Campanero MR, Armstrong M, Flemington E.

Mol Cell Biol. 1999 Dec;19(12):8442-50.

27.
28.
29.
30.

Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs.

Díaz-González F, González-Alvaro I, Campanero MR, Mollinedo F, del Pozo MA, Muñoz C, Pivel JP, Sánchez-Madrid F.

J Clin Invest. 1995 Apr;95(4):1756-65.

31.

ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands.

Campanero MR, Sánchez-Mateos P, del Pozo MA, Sánchez-Madrid F.

J Cell Biol. 1994 Nov;127(3):867-78.

32.

Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism.

del Pozo MA, Pulido R, Muñoz C, Alvarez V, Humbría A, Campanero MR, Sánchez-Madrid F.

Eur J Immunol. 1994 Nov;24(11):2586-94.

PMID:
7525295
33.

Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase.

Arroyo AG, Campanero MR, Sánchez-Mateos P, Zapata JM, Ursa MA, del Pozo MA, Sánchez-Madrid F.

J Cell Biol. 1994 Sep;126(5):1277-86.

34.

Domain-specific activation of neuronal migration and neurite outgrowth-promoting activities of laminin.

Calof AL, Campanero MR, O'Rear JJ, Yurchenco PD, Lander AD.

Neuron. 1994 Jul;13(1):117-30.

35.

Role of ICAM-3 in intercellular adhesion and activation of T lymphocytes.

del Pozo MA, Campanero MR, Sánchez-Mateos P, Arroyo AG, Pulido R, Muñoz C, Hernández-Caselles T, Aparicio P, Sánchez-Madrid F.

Cell Adhes Commun. 1994 Jul;2(3):211-8. No abstract available.

PMID:
7827957
36.

Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid.

Humbría A, Díaz-González F, Campanero MR, Arroyo AG, Laffón A, González-Amaro R, Sánchez-Madrid F.

Arthritis Rheum. 1994 Mar;37(3):342-8.

PMID:
7510491
37.

ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes.

Hernandez-Caselles T, Rubio G, Campanero MR, del Pozo MA, Muro M, Sanchez-Madrid F, Aparicio P.

Eur J Immunol. 1993 Nov;23(11):2799-806.

PMID:
8223855
38.

ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway.

Campanero MR, del Pozo MA, Arroyo AG, Sánchez-Mateos P, Hernández-Caselles T, Craig A, Pulido R, Sánchez-Madrid F.

J Cell Biol. 1993 Nov;123(4):1007-16.

39.

Co-clustering of beta 1 integrins, cytoskeletal proteins, and tyrosine-phosphorylated substrates during integrin-mediated leukocyte aggregation.

Sánchez-Mateos P, Campanero MR, Balboa MA, Sánchez-Madrid F.

J Immunol. 1993 Oct 1;151(7):3817-28.

PMID:
7690816
40.

Functional role of alpha 2/beta 1 and alpha 4/beta 1 integrins in leukocyte intercellular adhesion induced through the common beta 1 subunit.

Campanero MR, Arroyo AG, Pulido R, Ursa A, de Matías MS, Sánchez-Mateos P, Kassner PD, Chan BM, Hemler ME, Corbí AL, et al.

Eur J Immunol. 1992 Dec;22(12):3111-9.

PMID:
1446704
41.

Regulation of tumor necrosis factor (TNF)-alpha synthesis and TNF receptors expression in T lymphocytes through the CD2 activation pathway.

Santis AG, Campanero MR, Alonso JL, Sánchez-Madrid F.

Eur J Immunol. 1992 Dec;22(12):3155-60.

PMID:
1359970
42.

Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.

Santis AG, Campanero MR, Alonso JL, Tugores A, Alonso MA, Yagüe E, Pivel JP, Sánchez-Madrid F.

Eur J Immunol. 1992 May;22(5):1253-9.

PMID:
1577066
43.

Regulation of the VLA integrin-ligand interactions through the beta 1 subunit.

Arroyo AG, Sánchez-Mateos P, Campanero MR, Martín-Padura I, Dejana E, Sánchez-Madrid F.

J Cell Biol. 1992 May;117(3):659-70.

44.

Intrahepatic up-regulated expression of extracellular matrix protein receptors in chronic active hepatitis type B.

García-Monzón C, Moreno-Otero R, García-Buey L, García-Sánchez A, Campanero MR, Sánchez-Madrid F.

Gastroenterology. 1992 Jan;102(1):255-62.

PMID:
1370156
46.

Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism.

Campanero MR, Pulido R, Alonso JL, Pivel JP, Pimentel-Muiños FX, Fresno M, Sánchez-Madrid F.

Eur J Immunol. 1991 Dec;21(12):3045-8.

PMID:
1721026
47.

Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils.

Alvarez V, Pulido R, Campanero MR, Paraiso V, de Landázuri MO, Sánchez-Madrid F.

Kidney Int. 1991 Nov;40(5):899-905.

48.

Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active alpha 4 beta 1-fibronectin receptors upon B cell activation.

Postigo AA, Pulido R, Campanero MR, Acevedo A, García-Pardo A, Corbi AL, Sanchez-Madrid F, De Landazuri MO.

Eur J Immunol. 1991 Oct;21(10):2437-45.

PMID:
1833203
49.

Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.

Pulido R, Elices MJ, Campanero MR, Osborn L, Schiffer S, García-Pardo A, Lobb R, Hemler ME, Sánchez-Madrid F.

J Biol Chem. 1991 Jun 5;266(16):10241-5.

50.

An alternative leukocyte homotypic adhesion mechanism, LFA-1/ICAM-1-independent, triggered through the human VLA-4 integrin.

Campanero MR, Pulido R, Ursa MA, Rodríguez-Moya M, de Landázuri MO, Sánchez-Madrid F.

J Cell Biol. 1990 Jun;110(6):2157-65.

Supplemental Content

Loading ...
Support Center